Carla Balch is a tenured President and CEO with expertise building infrastructure and growth in the healthcare technology market by spearheading pioneering oncology software. Carla's motivation to create ground-breaking products and innovative market strategy is rooted in the belief every patient deserves the best care available and every employee deserves a great culture. The most successful strategic partnerships share this core motivation.
Carla is the CEO of TransMed Systems, Inc., a technology company specializing in data aggregation, enhancement and utility along with enterprise software for the benefit of improving healthcare clinical trials.
Previously, Carla served as President of Nantcare, a California-based oncology clinical trials and technology company. As President and CEO of Altos Solutions, the first web-based oncology electronic medical record and big data company, Carla led its sale to Flatiron Health, a Google-Ventures backed organization that was acquired by Roche for $2b.
Carla developed her passion for patients and technology as Director of Product Development and Sr. Financial Operations Manager of SOS/ACORN, an oncology research company and community research network formed from West Cancer Center in Memphis, TN.
A graduate of University of Memphis with a cum laude Master of Science in Psychology, Carla's commitment to the Healthcare community includes serving as Host of the Cancer Center Business Summit since 2004, and serving as a Healthcare Board Member of the Federal Reserve Bank in St. Louis, MO. She mentors start-up companies and has co-founded two new healthcare ventures. She lives in Memphis and enjoys traveling with her husband Lendon, a CTO and talented musician/songwriter.